Skip to main content
. 2022 Oct 7;12:971082. doi: 10.3389/fonc.2022.971082

Table 3.

Impact of different induction therapies on CR/CRi rate.

Group IA DA CAG P value
AML with BMF, n (%) 26 (57.78%) 14 (53.85%) 10 (41.67%) 0.446
AML without BMF, n (%) 12 (85.71%) 10 (62.50%) 21 (75.00%) 0.359

AML, acute myeloid leukemia; BMF, bone marrow fibrosis; CR, complete remission; CRi, morphologic complete remission with incomplete blood count recovery.